Home
.
Site map
.
Contact us
.
Disclaimer
.
Privacy policy
About Peplin
Company profile
Company history
Corporate strategy
Products & technology
Research and development
Drug development process
Clinical development
Pre-clinical development
Research
Research programs
Publications
Abstracts
Manufacturing process
Glossary
Target diseases
Actinic keratosis (AK)
Non-melanoma skin cancer (NMSC)
Leukemia
Bladder cancer
Corporate information
Board of directors
Executive management
Corporate directory
Corporate governance
Dermatology clinical advisory board
Investor information
ASX & media releases
PEPTalk
Reports to shareholders
Annual
Half yearly
Quarterly cashflow
Share price information
Securities trading
Major shareholders
FAQs
Links
News reports
Annual reports
.................................................................................
Current report
12-Dec-07
Notice of Special Meeting of Stockholders
2007 Financial Report
Archived
2006 Report
2005 Report
2004 Report
2003 Report
2002 Report
2001 Report
click
here
to download the Adobe reader
© Peplin 2008
click here to download the Adobe reader 
2006 Report
